For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Conor Medsystems, Inc.

USPTO Granted Patents = 25

% Expired Patents = 32.0

EPO Patents = 14

Forward Citations = 1,725

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

John Francis Shanley, Iv (22 out of 87 patents)

Kinam Park (3 out of 35 patents)

Neal L Eigler (3 out of 78 patents)

4. Theodore L Parker (3 out of 32 patents)

5. Elazer Reuven Edelman (3 out of 57 patents)

6. Stephen Hunter Diaz (2 out of 94 patents)

7. Ragina Naidu (1 out of 9 patents)

8. Prasanna Muralidharan (1 out of 5 patents)

9. Richard A Schatz (1 out of 15 patents)

10. Alan Saven (1 out of 1 patent)

11. Frank Litvack (17 patents)

12. Beau M Fisher (3 patents)

13. Theodore J Parker (0 patent)

14. Elazar R Edelman (0 patent)

Core Competencies:

Expandable Medical Device

Ductile Hinges

Flexible Hinges

Drug Delivery

Beneficial Agent

Restenosis Prevention

Stent Wall Structure

Controlled Release

Therapeutic Agent

Delivery Mechanism

Delivery System

Spatial Distribution

25 patents: Sort by Forward Citations

1. 8623068 - Expandable medical device with ductile hinges (2014-01-07),

2. 8353950 - Stent with flexible hinges (2013-01-15),

3. 8349390 - Method and apparatus for loading a beneficial agent into an expandable medical device (2013-01-08),

4. 8206435 - Expandable medical device for delivery of beneficial agent (2012-06-26),

5. 8197881 - Method and apparatus for loading a beneficial agent into an expandable medical device (2012-06-12),

6. 7909865 - Expandable medical device for delivery of beneficial agent (2011-03-22),

7. RE39800 - Method for preventing restenosis using a substituted adenine derivative (2007-08-27),

8. 7208011 - Implantable medical device with drug filled holes (2007-04-24),

9. 7208010 - Expandable medical device for delivery of beneficial agent (2007-04-24),

10. 7202370 - Semi-synthesis of taxane intermediates from 9-dihydro-13-acetylbaccatin III (2007-04-10),

11. 7179289 - Expandable medical device for delivery of beneficial agent (2007-02-20),

12. 7179288 - Expandable medical device for delivery of beneficial agent (2007-02-20),

13. 7169179 - Drug delivery device and method for bi-directional drug delivery (2007-01-30),

14. 7160321 - Expandable medical device for delivery of beneficial agent (2007-01-09),

15. D523558 - Stent wall structure (2006-06-20),

Company Overview

Conor Medsystems, Inc. is a medical technology company based in Menlo Park, California, specializing in the development of innovative drug-eluting stents and related cardiovascular devices. The company focuses on advancing treatment options for patients with coronary artery disease through its proprietary technologies, which aim to improve patient outcomes and reduce complications associated with traditional stenting procedures. Conor Medsystems is committed to research and development in the field of interventional cardiology, contributing to the evolution of minimally invasive therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

25 Patents

#64 in

#13,370 in

#25,730 in the World

Menlo Park, CA, United States of America

Conor Medsystems, Inc.

Forward Citations = 1,725

10 inventors:

John Francis Shanley, Iv (22 out of 87 patents)

Kinam Park (3 out of 35 patents)

Neal L Eigler (3 out of 78 patents)

4. Theodore L Parker (3 out of 32 patents)

5. Elazer Reuven Edelman (3 out of 57 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Conor Medsystems, Inc.. Retrieved from https://idiyas.com/company/conor-medsystems

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…